Respiratory
Boehringer Ingelheim has over 90 years of heritage in managing respiratory disease. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life
Unveiling the True Cost of COPD
17/07/2024 | Author: Boehringer Ingelheim
Document ID: PC-TH-104935
RELEATED CONTENT
21:02
The Power of Personalization with Inhaler Devices
13:01
Dual-Bronchodilators: A Game Changer in COPD Therapy
19:34
